Tower Research Capital (TRC)’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,436
Closed -$7K 6916
2022
Q2
$7K Buy
2,436
+644
+36% +$2.69K ﹤0.01% 4880
2022
Q1
$11K Buy
1,792
+552
+45% +$3.47K ﹤0.01% 4261
2021
Q4
$9K Buy
1,240
+330
+36% +$2.53K ﹤0.01% 4765
2021
Q3
$8K Sell
910
-2,638
-74% -$24.5K ﹤0.01% 4606
2021
Q2
$36K Buy
3,548
+1,661
+88% +$23.1K ﹤0.01% 3313
2021
Q1
$27K Buy
1,887
+717
+61% +$9.23K ﹤0.01% 3659
2020
Q4
$11K Sell
1,170
-12,550
-91% -$96K ﹤0.01% 4282
2020
Q3
$86K Sell
13,720
-5,216
-28% -$37.9K ﹤0.01% 3263
2020
Q2
$133K Buy
+18,936
New +$135K 0.01% 2199
2020
Q1
Sell
-1,078
Closed -$5K 4237
2019
Q4
$5K Buy
+1,078
New +$4.63K ﹤0.01% 2724
2019
Q2
Sell
-50
Closed 4536
2019
Q1
$0 Sell
50
-471
-90% -$1.71K ﹤0.01% 4506
2018
Q4
$2K Buy
+521
New +$1.79K ﹤0.01% 3479
2018
Q3
Sell
-197
Closed -$1K 4417
2018
Q2
$1K Buy
+197
New +$777 ﹤0.01% 3549
2018
Q1
Sell
-863
Closed -$3K 4047
2017
Q4
$3K Sell
863
-1,364
-61% -$5.73K ﹤0.01% 3134
2017
Q3
$11K Buy
2,227
+1,813
+438% +$8.71K ﹤0.01% 3044
2017
Q2
$2K Buy
+414
New +$1.77K ﹤0.01% 2402
2017
Q1
Sell
-2,548
Closed -$10K 4171
2016
Q4
$10K Buy
2,548
+2,254
+767% +$9.15K ﹤0.01% 2681
2016
Q3
$1K Sell
294
-1,248
-81% -$6.05K ﹤0.01% 3422
2016
Q2
$7K Buy
1,542
+811
+111% +$3.84K ﹤0.01% 3180
2016
Q1
$4K Buy
+731
New +$4.43K ﹤0.01% 2961
2015
Q4
Sell
-1,390
Closed -$12K 5247
2015
Q3
$12K Buy
1,390
+1,332
+2,297% +$9.63K ﹤0.01% 2184
2015
Q2
$0 Sell
58
-292
-83% -$1.83K ﹤0.01% 5227
2015
Q1
$2K Buy
350
+60
+21% +$303 ﹤0.01% 3867
2014
Q4
$1K Sell
290
-881
-75% -$3.91K ﹤0.01% 3770
2014
Q3
$5K Buy
+1,171
New +$5.27K ﹤0.01% 3332
2014
Q1
Sell
-1,446
Closed -$7K 5102
2013
Q4
$7K Buy
+1,446
New +$6.13K ﹤0.01% 3330
2013
Q3
Sell
-100
Closed 4937
2013
Q2
$0 Buy
+100
New +$291 ﹤0.01% 4000

Tower Research Capital (TRC)'s SMED Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 2,436 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in SMED in Q2 2013 and held it in 27 quarters. The position peaked at $133K in Q2 2020. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,436 Sharps Compliance Corp shares in Q3 2022, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in Sharps Compliance Corp in Q2 2013 and held it in 27 quarters.
  • Tower Research Capital (TRC)'s Sharps Compliance Corp position peaked at $133K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.